Cargando…
miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer
Gastric cancer (GC) is ranked the fourth leading cause of cancer-related death, with an over 75% mortality rate worldwide. In recent years, miR-299-3p has been identified as a biomarker in multiple cancers, such as acute promyelocytic leukemia, thyroid cancer, and lung cancer. However, the regulator...
Autores principales: | Wang, Zhenfen, Liu, Qing, Huang, Ping, Cai, Guohao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005920/ https://www.ncbi.nlm.nih.gov/pubmed/33817318 http://dx.doi.org/10.1515/biol-2021-0022 |
Ejemplares similares
-
Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis
por: Zhang, Weitong, et al.
Publicado: (2021) -
Circ_DOCK1 regulates USP11 through miR-132-3p to control colorectal cancer progression
por: Zhang, Weitong, et al.
Publicado: (2021) -
MiR-877 suppresses gastric cancer progression by downregulating
AQP3
por: Zhu, Hongyu, et al.
Publicado: (2020) -
Tumor-suppressive miR-299-3p inhibits gastric cancer cell invasion by targeting heparanase
por: Zhou, Xiangjun, et al.
Publicado: (2019) -
Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis
por: Yang, Xi, et al.
Publicado: (2020)